Aevum Therapeutics is a startup. Its most recent tracked round is Seed.
Aevum Therapeutics pioneers the discovery and development of therapeutic molecules derived from exercise, focusing on treatments for Parkinson’s disease and related neurodegenerative disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.